Biomarcatori di rischio cardiovascolare

Translated title of the contribution: Cardiovascular risk biomarkers

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Despite enormous therapeutic advances, cardiovascular disease remains a global public health problem. There is substantial interest in identifying new risk factors, to improve our understanding of disease biology and to account for the cases of heart disease that cannot be explained by known risk factors (smoking, diabetes, hypertension, obesity and history of coronary heart disease). Investigation of putative risk factors frequently involves the study of circulating biomarkers. Prior to the transfer from bench to bedside, these cardiovascular risk biomarkers have to meet the following requirements: 1) Can the clinician measure the biomarker?; 2) Does the biomarker add new information?; 3) Will the biomarker help the clinician manage patients? Until now, only few biomarkers have satisfactorily fulfilled these requirements.

Original languageItalian
Pages (from-to)240-244
Number of pages5
JournalGiornale di Gerontologia
Volume57
Issue number5
Publication statusPublished - Oct 2009

Fingerprint

Biomarkers
Coronary Disease
Heart Diseases
Cardiovascular Diseases
Public Health
Obesity
Smoking
Hypertension
Therapeutics

ASJC Scopus subject areas

  • Ageing
  • Geriatrics and Gerontology

Cite this

Biomarcatori di rischio cardiovascolare. / Marchegiani, Francesca; Provinciali, M.; Lattanzio, F.

In: Giornale di Gerontologia, Vol. 57, No. 5, 10.2009, p. 240-244.

Research output: Contribution to journalArticle

@article{0933e17d19ba4d87ba7481e0aba411fc,
title = "Biomarcatori di rischio cardiovascolare",
abstract = "Despite enormous therapeutic advances, cardiovascular disease remains a global public health problem. There is substantial interest in identifying new risk factors, to improve our understanding of disease biology and to account for the cases of heart disease that cannot be explained by known risk factors (smoking, diabetes, hypertension, obesity and history of coronary heart disease). Investigation of putative risk factors frequently involves the study of circulating biomarkers. Prior to the transfer from bench to bedside, these cardiovascular risk biomarkers have to meet the following requirements: 1) Can the clinician measure the biomarker?; 2) Does the biomarker add new information?; 3) Will the biomarker help the clinician manage patients? Until now, only few biomarkers have satisfactorily fulfilled these requirements.",
keywords = "Acute coronary syndrome, Biomarker, Genetics",
author = "Francesca Marchegiani and M. Provinciali and F. Lattanzio",
year = "2009",
month = "10",
language = "Italian",
volume = "57",
pages = "240--244",
journal = "Giornale di Gerontologia",
issn = "0017-0305",
publisher = "Pacini Editore s.r.l.",
number = "5",

}

TY - JOUR

T1 - Biomarcatori di rischio cardiovascolare

AU - Marchegiani, Francesca

AU - Provinciali, M.

AU - Lattanzio, F.

PY - 2009/10

Y1 - 2009/10

N2 - Despite enormous therapeutic advances, cardiovascular disease remains a global public health problem. There is substantial interest in identifying new risk factors, to improve our understanding of disease biology and to account for the cases of heart disease that cannot be explained by known risk factors (smoking, diabetes, hypertension, obesity and history of coronary heart disease). Investigation of putative risk factors frequently involves the study of circulating biomarkers. Prior to the transfer from bench to bedside, these cardiovascular risk biomarkers have to meet the following requirements: 1) Can the clinician measure the biomarker?; 2) Does the biomarker add new information?; 3) Will the biomarker help the clinician manage patients? Until now, only few biomarkers have satisfactorily fulfilled these requirements.

AB - Despite enormous therapeutic advances, cardiovascular disease remains a global public health problem. There is substantial interest in identifying new risk factors, to improve our understanding of disease biology and to account for the cases of heart disease that cannot be explained by known risk factors (smoking, diabetes, hypertension, obesity and history of coronary heart disease). Investigation of putative risk factors frequently involves the study of circulating biomarkers. Prior to the transfer from bench to bedside, these cardiovascular risk biomarkers have to meet the following requirements: 1) Can the clinician measure the biomarker?; 2) Does the biomarker add new information?; 3) Will the biomarker help the clinician manage patients? Until now, only few biomarkers have satisfactorily fulfilled these requirements.

KW - Acute coronary syndrome

KW - Biomarker

KW - Genetics

UR - http://www.scopus.com/inward/record.url?scp=75349095440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75349095440&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:75349095440

VL - 57

SP - 240

EP - 244

JO - Giornale di Gerontologia

JF - Giornale di Gerontologia

SN - 0017-0305

IS - 5

ER -